Caribou Biosciences, Inc. (CRBU)
0.4232
-0.02
(-4.90%)
USD |
NASDAQ |
Oct 30, 16:00
0.43
+0.01
(+1.61%)
After-Hours: 20:00
Caribou Biosciences Market Cap : 44.86M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 44.86M |
| October 29, 2026 | 47.17M |
| October 28, 2026 | 51.87M |
| October 27, 2026 | 48.83M |
| October 26, 2026 | 52.17M |
| October 23, 2026 | 56.47M |
| October 22, 2026 | 59.36M |
| October 21, 2026 | 57.70M |
| October 20, 2026 | 55.01M |
| October 19, 2026 | 49.18M |
| October 16, 2026 | 49.81M |
| October 15, 2026 | 49.26M |
| October 14, 2026 | 48.77M |
| October 13, 2026 | 49.82M |
| October 12, 2026 | 52.67M |
| October 09, 2026 | 48.78M |
| October 08, 2026 | 51.01M |
| October 07, 2026 | 65.44M |
| October 06, 2026 | 120.31M |
| October 05, 2026 | 126.13M |
| October 02, 2026 | 129.31M |
| October 01, 2026 | 129.31M |
| September 30, 2026 | 134.61M |
| September 29, 2026 | 131.43M |
| September 28, 2026 | 130.37M |
| Date | Value |
|---|---|
| September 25, 2026 | 131.43M |
| September 24, 2026 | 132.49M |
| September 23, 2026 | 136.73M |
| September 22, 2026 | 142.03M |
| September 21, 2026 | 137.79M |
| September 18, 2026 | 137.79M |
| September 17, 2026 | 138.85M |
| September 16, 2026 | 132.49M |
| September 15, 2026 | 134.61M |
| September 14, 2026 | 136.73M |
| September 11, 2026 | 134.61M |
| September 10, 2026 | 145.21M |
| September 09, 2026 | 152.63M |
| September 08, 2026 | 163.23M |
| September 04, 2026 | 166.41M |
| September 03, 2026 | 166.41M |
| September 02, 2026 | 169.59M |
| September 01, 2026 | 164.29M |
| August 31, 2026 | 163.23M |
| August 28, 2026 | 171.71M |
| August 27, 2026 | 175.95M |
| August 26, 2026 | 174.89M |
| August 25, 2026 | 186.55M |
| August 24, 2026 | 173.83M |
| August 21, 2026 | 175.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Anavex Life Sciences Corp. | 110.31M |
| Intellia Therapeutics, Inc. | 1.746B |
| Vir Biotechnology, Inc. | 1.912B |
| Vaxcyte, Inc. | 8.981B |
| Foghorn Therapeutics, Inc. | 122.13M |
Market Cap Related Metrics
| PS Ratio | 4.056 |
| Price to Book Value | 0.4573 |
| Price | 0.4232 |
| Earnings Yield | -254.6% |